Edgewise Therapeutics Inc. Common Stock vs Virgin Galactic Holdings, Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while Virgin Galactic Holdings, Inc. trades at $2.55 (market cap $398.70M). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 9.9× Virgin Galactic Holdings, Inc.'s market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Virgin Galactic Holdings, Inc. for 70 Days on average.
| EWTX | SPCE | |
|---|---|---|
Market Cap | $3.94B | $398.70M |
Volume | 810,104 | 5,790,856 |
Sector | Health | Industrials |
52-Week High | $48.35 | $7.52 |
52-Week Low | $14.89 | $2.17 |
Typical Hold Time | 0 Days | 70 Days |
Enterprise Value | $3.48B | $362.68M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Virgin Galactic (SPCE) trades at $2.55, down 4.49% on the day, reflecting ongoing investor concerns about delayed commercial operations. The company continues to report significant losses with negative profit margins exceeding 23,800% and negative cash flow, though recent earnings have beaten expectations. Technical indicators show a bearish trend with oversold conditions, while management maintains guidance for positive cash flow by 2027.
The outlook remains highly speculative with substantial execution risk. While space tourism represents a long-term growth opportunity, SPCE faces persistent financial challenges including cash burn, stock dilution, and competitive pressures. Analyst sentiment is divided with no clear consensus, making this suitable only for risk-tolerant investors betting on successful commercialization.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →